Drugs interacting with G protein alpha subunits: selectivity and perspectives

Area of Science:

• Biochemistry
• Molecular Biology
• Pharmacology

Background:

• Extracellular signals (hormones, neurotransmitters, photons) mediate cellular functions via signal transduction pathways.
• These pathways involve receptors, G proteins, and effectors, crucial for cellular communication.
• Compounds interacting with G proteins can modulate these pathways, offering therapeutic potential.

Purpose of the Study:

• To investigate the binding sites on G proteins for potential drug targets.
• To explore the design of synthetic ligands that stimulate or inhibit G protein activity.
• To identify specific interactions for developing selective G protein modulators.

Main Methods:

• Analysis of G alpha protein binding sites, including effector and GTP binding sites.
• Review of experimental strategies to understand receptor-G protein specificity.
• Examination of existing compounds (mastoparan, GPAnt-2, suramin, benzalkonium chloride, methoctramine) for their G protein interactions.

Main Results:

• The effector binding site is a target for selective exogenous ligands.
• The GTP binding site shows high homology across G protein families, limiting its use for subclass discrimination.
• The receptor binding site of G proteins demonstrates specificity and is a promising drug target.

Conclusions:

• Targeting the receptor-G protein interaction site is crucial for developing selective G protein antagonists.
• Compounds like mastoparan, GPAnt-2, and suramin are lead compounds for antagonist design.
• Understanding these interactions aids in delineating G protein functions, explaining drug side effects, and developing novel therapeutics.